Efficacy of Ustekinumab for the treatment of perianal fistulizing Crohn’s disease: a multicentre retrospective study - Poll - MDSpire

Efficacy of Ustekinumab for the treatment of perianal fistulizing Crohn’s disease: a multicentre retrospective study

  • By

  • Youran Li

  • Xiaomei Sun

  • Ke Wen

  • Lu Lu

  • Wei Wang

  • Minna Wu

  • Jiaze Ma

  • Zailong Zhou

  • Yunfei Gu

  • July 10, 2026

  • 0 min

Share

Original Source(s)

Efficacy of Ustekinumab for the treatment of perianal fistulizing Crohn’s disease: a multicentre retrospective study

  • by Youran Li, Xiaomei Sun, Ke Wen, Lu Lu, Wei Wang, Minna Wu, Jiaze Ma, Zailong Zhou, Yunfei Gu

  • July 10, 2026

Related Content

Safety evaluation of subcutaneous and intravenous administration of infliximab: a real-world study based on the FAERS database

Nurr1 deficiency orchestrates a coupled liver–gut pathological axis revealed by multi-omics and deep-learning histopathology

AF6 orchestrates macrophage polarization via JAK2-STAT3 signaling and supports intestinal regeneration by stimulating stem cell proliferation